Allelica and Invitae aim to decrease the gap in polygenic risk score (PRS) performance in individuals from diverse genetic ancestries, ensuring that the life-saving integration of genomic information into breast cancer risk assessments can benefit all women NEW YORK — Allelica has formalized a partnership with Invitae Corporation (NYSE: NVTA), a leading medical genetics company, to build a […]
Cambridge, United Kingdom – Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, announces the appointment of Dr. Tom Barber as Chief Scientific Officer. Dr. Barber will lead the development and delivery of Congenica’s scientific and clinical vision to become the global leader in genome annotation […]
CYTENA’s C.STATION™ and ExcellGene’s CHOExpress® will Reduce Timelines to Generate Clonal Cell Lines Monthey, Switzerland & Freiburg, Germany – Today, CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant […]
RNAstorm™ and DNAstorm™ RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors Fremont, CA – Life Science Newswire – Biotium, a supplier of cutting-edge life science reagents, is announcing the acquisition of Cell Data Sciences RNAstorm™ and DNAstorm™ kits for RNA/DNA extraction. Biotium, which previously distributed the Cell Data Sciences […]
AMSBIO announce the launch of its StemFit Purotein® range of high purity, high activity recombinant proteins for cell therapy applications. Continued expansion of cell therapy applications across healthcare and the life sciences is driving a rapidly increasing need for clinically applicable ancillary materials. A key requirement is for recombinant proteins, such as growth factors and […]
LEIDEN, The Netherlands — MIMETAS, a global leader in Organ-on-a-Chip models and technology, announces today that it has expanded its license to the HUB Organoid Technology to include all organs. The license covers organoid technology developed by Professor Hans Clevers, a pioneer in adult stem cells. “This is a crucial addition to our Organ-on-a-Chip disease models,” says Jos […]
SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an automation and instrumentation company focused on cell therapy manufacturing, today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer. A veteran of the cell and gene therapy industry, Dr. Eaker will be responsible for driving Xcellbio’s instrument and software development strategy and the commercial delivery […]
Propath UK is the first contract research organization in Europe to offer COMET™ services to biopharmaceutical researchers. LAUSANNE, Switzerland and HEREFORD, United Kingdom – Lunaphore, a Swiss life sciences company developing technologies to enable spatial biology in every laboratory, today announced that it has deployed its COMET™ PA instrument at Propath UK, one of Europe’s leading contract research organizations (CRO). […]
Asteria©, our latest breakthrough single-cell RNA-sequencing kit, is now commercially available for all researchers worldwide. This innovative hydrogel-based benchtop kit enables the transcriptomic profiling of 10,000 individual cells per sample, instrument-free. By purchasing the kit, researchers also gain access to its intuitive and entirely cloud-based analysis software Cytonaut©. The combination of the kit and software is a […]
CINCINNATI, Ohio — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. The transaction closed on April 30, 2022. EUPROTEIN Inc. offers custom development and production of […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
